RNS Announcements

Notice of Annual General Meeting

30 May 2025

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that Notice convening the Company's Annual General Meeting for 11:00 am on 27 June 2025 at the offices of Gerald Edelman, 73 Cornhill, London EC3V 3QQ, will be posted today to shareholders as part of the published accounts and will be available shortly on the Company's website at www.probiotixhealth-ir.com


For further information, please contact:

ProBiotix Health plc

https://probiotixhealth-ir.com/

 

[email protected]

Steen Andersen, Chief Executive Officer

Miles Nolan, Investor Relations

 



Peterhouse Capital Limited

Aquis Corporate Adviser and Broker

 

 

 

Mark Anwyl

Duncan Vasey

 

Tel: 020 7469 0930

 


Notes to Editors:

ProBiotix is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.

The Company has a unique approach: discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.

back to RNS & Investor News